Insider · CIK 0001634730
Jason Matuszewski
ceoofficerdirectorowner
Files at BSEM (BioStem Technologies, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Common Stock | +250,000 | $2.00 | $500k | 1,553,551 | 3 d ago |
| Oct 7, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Options (Right to Buy)derivative | -250,000 | $0.00 | $0 | 2,000,000 | 3 d ago |
| Sep 15, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Common Stock | +8,469 | $0.00 | $0 | 1,286,902 | 25 d ago |
| Sep 17, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Common Stock | +16,650 | $0.00 | $0 | 1,303,552 | 25 d ago |
| Sep 15, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Restricted Stock Unitsderivative | -8,469 | $0.00 | $0 | 33,874 | 25 d ago |
| Sep 17, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,650 | $0.00 | $0 | 99,900 | 25 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.